APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced ST

Clinical trial NCT06687070 · RECRUITING

Trial details

NCT number: NCT06687070
Sponsor: Ascentage Pharma Group Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Platinum-resistant Recurrent Ovarian Cancer Advanced Solid Tumor

Start date: 2024-12-17
Primary completion: 2027-05-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.